Trial Profile
Randomized Trial of Cyclosporine + CAMPATH-1H (ALEMTUZUMAB) vs. Cyclosporine + METHOTREXATE in Patients Diagnosed With Mature B-cell Neoplasms - Chronic Lymphocytic Leukemia and Low-grade Lymphomas - Receiving Allogeneic Hematopoietic Stem Cell Transplantation With Nonmyeloablative Conditioning Regimen
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary) ; Ciclosporin; Methotrexate
- Indications Chronic lymphocytic leukaemia; Follicular lymphoma; Lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 28 Dec 2017 Status changed from suspended to discontinued.
- 12 Mar 2016 New trial record